Sarclisa 100 mg/5 mL
Sarclisa 100 mg/5 mL is a medicine authorised by Swissmedic under authorisation number 67525. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 March 2020 and the authorisation is valid without a time limit. ATC code L01FC02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67525 |
|---|---|
| Name | Sarclisa 100 mg/5 mL |
| Full name | Sarclisa 100 mg/5 mL , solution à diluer pour perfusion |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FC02 |
| First authorisation | 18 March 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sarclisa 100 mg/5 mL , solution à diluer pour perfusion | A | 18 March 2020 |
| 2 | Sarclisa 500 mg/25 mL , solution à diluer pour perfusion | A | 18 March 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FC02 | 07.16.1. | A |
| 2 | 3 | Durchstechflasche(n) | L01FC02 | 07.16.1. | A |
| 3 | 1 | Durchstechflasche(n) | L01FC02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Sarclisa 100 mg/5 mL authorised in Switzerland?
Yes. Sarclisa 100 mg/5 mL is authorised by Swissmedic under authorisation number 67525, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Sarclisa 100 mg/5 mL have?
Sarclisa 100 mg/5 mL is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Sarclisa 100 mg/5 mL?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.